ARCH Venture Fund IX, L.P.
10% owner at Vir Biotechnology.
- Rank
- 780th of 809
- Companies held
- 1
- Largest holding
- VIR, 100.0% of total
- Latest SEC filing
- Aug 31, 2022
- Listed but not counted
- $56.2M
What the $54.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vir Biotechnology VIR Common Stock | Indirectly (see filing footnote) | 6,061,570 | $8.87 | $53.8M | 98.7% | Form 4, Aug 31, 2022 |
| Vir Biotechnology VIR Common Stock | Indirectly (see filing footnote) | 55,250 | $8.87 | $490K | 0.9% | Form 4, Aug 31, 2022 |
| Vir Biotechnology VIR Common Stock | Directly | 27,608 | $8.87 | $245K | 0.4% | Form 4, Aug 31, 2022 |
Share counts are the amounts ARCH Venture Fund IX, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on ARCH Venture Fund IX, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vir Biotechnology VIR Common Stock | Through ARCH Venture Fund IX, L.P. Held by a company or fund the insider manages | 6,279,351 | $8.87 | $55.7M | — | Form 4, Aug 30, 2022 |
| Vir Biotechnology VIR Common Stock | Through ARCH Venture Fund IX Overage, L.P. Held by a company or fund the insider manages | 52,298 | $8.87 | $464K | — | Form 4, Aug 30, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 777 | John & Daria Barry Foundation 10% owner, Prospect Capital | $55.1M |
| 778 | Catalyst Sponsor LLC 10% owner, Catalyst Acquisition | $54.6M |
| 779 | Just Rocks, Inc. 10% owner, Brilliant Earth Group | $54.5M |
| 780 | ARCH Venture Fund IX, L.P. 10% owner, Vir Biotechnology | $54.5M |
| 781 | ICONIQ Strategic Partners VI GP, L.P. 10% owner, Braze | $54.4M |
| 782 | Alyeska Master Fund, L.P. 10% owner, FrontView REIT | $54.2M |
| 783 | Johnson & Johnson Innovation - JJDC, Inc. 10% owner, MeiraGTx Holdings | $54.1M |
Other Vir Biotechnology insiders
All VIR insiders- George A. Scangos$23.6MDirector. #3690 overall
- Vicki L. Sato$9.6MDirector. #7843 overall
- Backer Marianne De$9.4MPresident and CEO. #8333 overall
- Robert Nelsen$5.5MDirector. #13445 overall
- Phillip A. Sharp$1.5MDirector. #2946 overall
- Ramy Farid$284KDirector. #8182 overall
Questions
How much stock does ARCH Venture Fund IX, L.P. own?
ARCH Venture Fund IX, L.P. holds $54,501,076 in listed stock based on SEC filings and current prices, mostly Vir Biotechnology (VIR). That ranks 780th on the Stock Rich List.
Is this ARCH Venture Fund IX, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Keith Crandell, SEC filer 1219043.